FDAcategoryC

A designation by the US FDA signifying that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Properties

{ "id": "https://schema.org/FDAcategoryC", "label": "FDAcategoryC", "comment": "A designation by the US FDA signifying that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.", "subTypeOf": "https://schema.org/DrugPregnancyCategory", "enumerationtype": "https://schema.org/DrugPregnancyCategory", "equivalentClass": "", "properties": "", "subTypes": "", "supersedes": "", "supersededBy": "", "isPartOf": "" }